Richard M. Philpot
- Pharmacology top 0.2%
- Molecular Biology top 10%
- Oncology top 10%
- Cancer Research top 5%
- Biochemistry top 1%
- Co-authors
- Ernest HodgsonC. Roland WolfJohn R. BendCosette J. Serabjit‐SinghLila H. OverbyBarbara A. DominCharles G. PlopperSharon L. Ripp
- Topics
- Pharmacogenetics and Drug Metabolism (34 papers)Drug Transport and Resistance Mechanisms (13 papers)Carcinogens and Genotoxicity Assessment (9 papers)
- Partner nations
- United StatesAustraliaSri Lanka
In The Last Decade
Richard M. Philpot
54 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 108
- Pharmacology 997
- Molecular Biology 815
- Oncology 440
- Cancer Research 409
- Biochemistry 331
Countries citing papers authored by Richard M. Philpot
This map shows the geographic impact of Richard M. Philpot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard M. Philpot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard M. Philpot more than expected).
Fields of papers citing papers by Richard M. Philpot
This network shows the impact of papers produced by Richard M. Philpot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard M. Philpot. The network helps show where Richard M. Philpot may publish in the future.
Co-authorship network of co-authors of Richard M. Philpot
This figure shows the co-authorship network connecting the top 25 collaborators of Richard M. Philpot. A scholar is included among the top collaborators of Richard M. Philpot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard M. Philpot. Richard M. Philpot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 38 | |
| 2 | 66 | |
| 3 | 13 | |
| 4 | 17 | |
| 5 | 60 | |
| 6 | 32 | |
| 7 | 50 | |
| 8 | 116 | |
| 9 | 32 | |
| 10 | 34 | |
| 11 | 27 | |
| 12 | 68 | |
| 13 | 17 | |
| 14 | 35 | |
| 15 | 19 | |
| 16 | 49 | |
| 17 | 76 | |
| 18 | Reviews in biochemical toxicology | 205 |
| 19 | 39 | |
| 20 | 8 |
About Richard M. Philpot
Richard M. Philpot is a scholar working on Pharmacology, Biochemistry and Pharmaceutical Science, having authored 54 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (34 papers), Drug Transport and Resistance Mechanisms (13 papers) and Carcinogens and Genotoxicity Assessment (9 papers). The work is most often cited by research in Pharmacology (997 citations), Biochemistry (331 citations) and Cancer Research (409 citations). Richard M. Philpot has collaborated with scholars based in United States, Australia and Sri Lanka. Frequent co-authors include Ernest Hodgson, C. Roland Wolf, John R. Bend, Cosette J. Serabjit‐Singh, Lila H. Overby, Barbara A. Domin, Charles G. Plopper, Sharon L. Ripp, Adnan A. Elfarra and Theodora R. Devereux. Their work appears in journals such as Science, Journal of Biological Chemistry and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.